Exercise News and Research

Latest Exercise News and Research

Provectus Pharmaceuticals receives $7.5M in private placement offering

Provectus Pharmaceuticals, Inc., a development-stage oncology and dermatology biopharmaceutical company, announced today that it has received gross proceeds of approximately $7.5 million in a private placement offering to institutional and accredited investors. In connection with the closing, the Company issued approximately 10.0 million shares of its convertible preferred stock and warrants to purchase approximately 5.0 million shares of its common stock at an exercise price of $1.00 per share.

12 Mar 2010

Penn-ICOWHI conference to examine how urban environments affect women's health

Women comprise more than half the population of the nation's cities, are three times as likely as their male counterparts to live alone after the age of 65, and are primary caregivers for their families at all ages and stages of life. The University of Pennsylvania School of Nursing, with the International Congress of Women's Health Issues, will host "Cities and Women's Health: Global Perspectives," Wednesday, April 7, through Saturday, April 10, on Penn's campus to examine how urban environments affect their health.

12 Mar 2010

Managing back pain without costly medications: High-touch Integrative Medicine therapies may help

A new pilot study conducted with assembly workers at the Ford Motor Company in Louisville, KY focused on acute, work-related low back pain. Results of that study indicate that high-touch Integrative Medicine (IM) therapies can help employees manage back pain without the costly medications typically associated with managing their pain.

12 Mar 2010

Micromet prices public offering at $7.00 per share

Micromet, Inc. announced today the pricing of an underwritten public offering of 10 million shares of common stock at a public offering price of $7.00 per share. The Company has granted the underwriters a 30-day option to purchase an additional 1.5 million shares of common stock from the Company. All of the shares in the offering are being sold by Micromet. The closing of the offering is expected to take place on March 17, 2010, subject to the satisfaction of customary closing conditions.

12 Mar 2010

High-intensity workout as effective as traditional types of exercise: study

The usual excuse of "lack of time" for not doing enough exercise is blown away by new research published in The Journal of Physiology.

12 Mar 2010

Democrats close to health bill deal as some Democrats - and all Republicans - hold out

Congressional Democrats, reportedly closing in on a final health reform agreement, are seeking to alleviate concerns of reluctant members.

12 Mar 2010

OXiGENE signs definitive agreement to sell Common Stock

OXiGENE, Inc., a clinical-stage biopharmaceutical company developing novel therapeutics to treat cancer and eye diseases, today announced that it has entered into a definitive agreement with certain institutional investors to sell 6,578,945 shares of its Common Stock and separate series of warrants to purchase Common Stock in a private placement.

12 Mar 2010

Restrictions on physician work hours may lead to more miscommunication

As shifts change in a hospital, outgoing physicians must "hand off" important information to their replacements in a brief meeting. But a new study of this hand-off process finds that the most important information is not fully conveyed in a majority of cases, even as physicians rate their communication as successful.

11 Mar 2010

NeoMed invests in CytoCore

CytoCore Inc., the developer of cost-effective products used in the practice of cytology for the detection and diagnosis of cancer and cancer related diseases, announced today that NeoMed has made an investment in CytoCore Inc.

11 Mar 2010

National Public Health Agenda for Osteoarthritis launched with assistance from UNC

Betty Isaacs of Boone, N.C., knows all about the chronic pain of osteoarthritis and the impact it has on her life. "The pain in my knee was so bad, I would just sit around," Isaacs said.

11 Mar 2010

StemCells reports net loss of $5.23M for fourth-quarter fiscal 2009

StemCells, Inc. today reported financial results for the fourth quarter and year ended December 31, 2009. The Company's results include the operations of Stem Cell Sciences Plc (SCS) since April 1, 2009.

11 Mar 2010

Columbia Laboratories' fourth-quarter 2009 net revenues up 21%

Columbia Laboratories, Inc. today reported financial results of the three- and twelve-months periods ended December 31, 2009.

11 Mar 2010

Senetek closes Security Purchase Agreement with DMRJ

Senetek PLC today announced the closing of a Security Purchase Agreement, a Note and a Warrant Purchase Agreement DMRJ Group, LLC on March 4, 2010. DMRJ Group, LLC is a Delaware limited liability company affiliated with Platinum Partners Value Arbitrage Fund L.P., an accredited institutional investor with its investment manager headquartered in New York, New York.

11 Mar 2010

Great Point and Deerfield invest in BioSante Pharmaceuticals

BioSante Pharmaceuticals, Inc. today announced the closing of the sale, directly to funds affiliated with two institutional investors, of an aggregate of approximately 10.4 million shares of BioSante’s common stock and warrants to purchase up to approximately 5.2 million shares of its common stock, resulting in gross cash proceeds to BioSante of $18 million.

11 Mar 2010

Watson Pharmaceuticals resolves Actos patent litigation

Watson Pharmaceuticals, Inc, today announced that it has reached a settlement agreement with Takeda Pharmaceutical Company Limited and Takeda Pharmaceuticals North America resolving outstanding patent litigation related to Watson's generic equivalent version of Actos® (Pioglitazone Hydrochloride) 15mg, 30mg and 45mg tablets.

11 Mar 2010

Majority of nurse practitioners recommend dietary supplements for overall health and wellness

Eighty-five percent of nurse practitioners agree that one of the roles of healthcare professionals is to provide their patients with information about dietary supplements, according to new research from the "Life...supplemented" 2009 Healthcare Professionals (HCP) Impact Study.

11 Mar 2010

Regence acquires assets of Kinetix Living

As part of its continued focus on developing programs designed to meet employers' needs, Regence has acquired the assets of Kinetix Living Corp., a Seattle-based company that provides customized health and nutrition programs to corporate clients and individuals throughout the country.

11 Mar 2010

Nabi Biopharmaceuticals closes exclusive option and license agreement for NicVAX with GSK

Nabi Biopharmaceuticals announced today that the closing requirements set forth in the exclusive option and license agreement for NicVAX® (Nicotine Conjugate Vaccine), dated November 13, 2009 with GlaxoSmithKlineBiologicals S.A. have been met and the companies have closed the agreement.

11 Mar 2010

Regence Blueshield acquires Seattle-based health and wellness company

Maveron LLC, a Seattle-based venture capital firm focused on helping exceptional entrepreneurs build great consumer businesses, announced the asset acquisition of portfolio company Kinetix Living Corp. by Regence BlueShield of Washington. Terms of the transaction were not disclosed.

11 Mar 2010